CD4 and melanoma: Intralesional T-VEC has been associated with an increase in melanoma-specific CD8 T cells and a corresponding decrease in suppressive immune cells, such as CD4+ FoxP3+ regulatory T cells and MDSCs within the tumor microenvironment [182].